RxDoctor Payments Data

Megan Moore

Adult Health · Philadelphia, PANPI 1184993495

Payments from drug & device makers

$2,798in general payments, 2019–2025

Across 41 payments — averaging $68.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Argenx US, Inc.$2K
  • AbbVie$201
  • UCB, Inc.$134
  • Pfizer$94
  • Averitas Pharma Inc.$74
  • AstraZeneca$61
  • plus $48 from 2 others

What the payments were for

  • Travel & lodging$1,83165%
  • Food & beverage$96635%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,798 in reported general payments places this provider in the 85th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$9,023
Medicare patients
64
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate29$56,169
UbrelvyUbrogepant29$32,931
VimpatLacosamide11$27,410
Lacosamide26$2,884
Levetiracetam40$2,427
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine17$868
Zonisamide16$816
Lamotrigine33$724
Bupropion XlBupropion Hcl24$714
Gabapentin29$688
Amitriptyline Hcl45$578
Methylphenidate Hcl45$538
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine25$445
Escitalopram Oxalate41$361
Clonazepam24$267

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$94$56,16929 claims
AbbVieUbrelvy$201$32,93129 claims
UCB, Inc.Vimpat$134$27,41011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 899 adult health providers in Pennsylvania.

Other adult health in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →